Invasive group B streptococcal disease in two pediatric patients with systemic lupus erythematosus
- PMID: 23691410
- PMCID: PMC3638523
- DOI: 10.1155/2013/896014
Invasive group B streptococcal disease in two pediatric patients with systemic lupus erythematosus
Abstract
Systemic lupus erythematosus (SLE) is an autoimmune disease associated with high morbidity and mortality, often caused by infection. We report two patients with SLE who were treated with steroids and immunosuppressive medication and then developed invasive Group B Streptococcus (GBS) infections. While GBS infection is rare in the nonneonatal pediatric age group, GBS should be considered when treating SLE patients presenting with signs of infection.
References
-
- Petri M. Infection in systemic lupus erythematosus. Rheumatic Disease Clinics of North America. 1998;24(2):423–456. - PubMed
-
- Gladman DD, Hussain F, Ibañez D, Urowitz MB. The nature and outcome of infection in systemic lupus erythematosus. Lupus. 2002;11(4):234–239. - PubMed
-
- Skoff TH, Farley MM, Petit S, et al. Increasing burden of invasive group B Streptococcal disease in nonpregnant adults, 1990–2007. Clinical Infectious Diseases. 2009;49(1):85–92. - PubMed
-
- Kim BS, Kim SH, Kim SJ, et al. An unusual complication of systemic lupus erythematosus: bacterial meningitis caused by streptococcus agalactiae. Journal of the European Academy of Dermatology and Venereology. 2007;21(9):1274–1275. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources